SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126515
Filing Date
2024-11-13
Accepted
2024-11-13 17:25:53
Documents
102
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atai-20240930.htm   iXBRL 10-Q 3845497
2 EX-31.1 atai-ex31_1.htm EX-31.1 15107
3 EX-31.2 atai-ex31_2.htm EX-31.2 16418
4 EX-31.3 atai-ex31_3.htm EX-31.3 17188
5 EX-32.1 atai-ex32_1.htm EX-32.1 19183
6 GRAPHIC img106867992_0.jpg GRAPHIC 84765
  Complete submission text file 0000950170-24-126515.txt   19023067

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atai-20240930.xsd EX-101.SCH 3184158
104 EXTRACTED XBRL INSTANCE DOCUMENT atai-20240930_htm.xml XML 3702658
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40493 | Film No.: 241455784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)